Gastric Carcinoma

Hallissey MT, Allum WH, Jewkes AJ, Ellis DJ, Fielding JW. Early detection of gastric cancer.BMJ 1990;301:513–5. Parsonnet J, Hansen S, Rodriguez L, et al.Helicobacter pylori infection and gastric lymphoma.N Engl J Med 1994;330:1267–71. Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negativeHelicobacter pylori infection.Gut 1997;40:297–301. Blaser MJ, Perez-Perez GI, Kleanthous H, et al. Infection withHelicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach.Cancer Res 1995;55:2111–5. Luketich JD, Schauer PR, Meltzer CC, et al. Role of positron emission tomography in staging esophageal cancer.Ann Thorac Surg 1997;64:765–9. Lowy AM, Mansfield PF, Leach SD, Ajani J. Laparoscopic staging for gastric cancer.Surgery 1996;119:611–4. Burke EC, Karpeh MS, Conlon KC, Brennan MF. Laparoscopy in the management of gastric adenocarcinoma.Ann Surg 1997;225:262–7. Bonekamp JJ, Songun I, Hermans J, van de Velde CJ. Prognostic value of positive cytology findings from abdominal washings in patients with gastric cancer.Br J Surg 1996;83:672–4. Gouzi JL, Huguier M, Fagniez PL, et al. Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum: a French prospective controlled study.Ann Surg 1989;209:162–6. Bozzetti F, Marubini E, Bonfanti G, et al. Total versus subtotal gastrectomy: surgical morbidity and mortality rates in a multicenter Italian randomized trial (The Italian Gastrointestinal Tumor Study Group).Ann Surg 1997;226:613–20. Shiu MH, Moore E, Sanders M, et al. Influence of the extent of resection on survival after curative treatment of gastric carcinoma: a retrospective multivariate analysis.Arch Surg 1987;122:1347–51. Siewert JR, Bottcher K, Roder JD, Busch R, Hermanek P, Meyer HJ. Prognostic relevance of systematic lymph node dissection in gastric carcinoma (German Gastric Carcinoma Study Group).Br J Surg 1993;80:1015–8. Jaehne J, Meyer HJ, Maschek H, Geerlings H, Burns E, Pichlmayr R. Lymphadenectomy in gastric carcinoma: a prospective and prognostic study.Arch Surg 1992;127:290–4. Cuschieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial (The Surgical Cooperative Group).Lancet 1996;347:995–9. Bonenkamp JJ, Songun I, Hermans J, et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients.Lancet 1995;345:745–8. Sasako M, Maruyama K, Kinoshita T, Bonenkamp JJ, van de Velde CJ, Hermans J. Quality control of surgical technique in a multicenter, prospective, randomized, controlled study on the surgical treatment of gastric cancer.Jpn J Clin Oncol 1992;22:41–8. Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H, Okajima K. Pancreas-preserving total gastrectomy for proximal gastric cancer.World J Surg 1995;19:532–6. Griffith JP, Sue-Ling HM, Martin I, et al. Preservation of the spleen improves survival after radical surgery for gastric cancer.Gut 1995;36:684–90. Wanebo HJ, Kennedy BJ, Chmiel J, Steele G Jr, Winchester D, Osteen R. Cancer of the stomach: a patient care study by the American College of Surgeons.Ann Surg 1993;218:583–92. Roder JD, Bottcher K, Busch R, Wittekind C, Hermanek P, Siewert JR. Classification of regional lymph node metastasis from gastric carcinoma (German Gastric Cancer Study Group).Cancer 1998;82:621–31. Nakajima T, Ota K, Ishihara S, Oyama S, Nishi M, Hamashima N. Meta-analysis of 10 postoperative adjuvant chemotherapies for gastric cancer in CIH.Gan To Kagaku Ryoho 1994;21:1800–5. Hermans J, Bonenkamp JJ, Boon MC, et al. Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials.J Clin Oncol 1993;11:1441–7. Preusser P, Wilke H, Achterrath W, et al. Phase-II-study with EAP (etoposide, adriamycin, cis-platinum) in patients with primary inoperable gastric cancer and advanced disease.Recent Results Cancer Res 1988;110:198–206. Klein HO. Long-term results with FAMTX (5-fluorouracil, adriamycin, methotrexate) in advanced gastric cancer.Anticancer Res 1989;9:1025–6. Kelsen D, Atiq OT, Saltz L, et al. FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.J Clin Oncol 1992;10:541–8. Kelsen D. Neoadjuvant therapy for gastrointestinal cancers.Oncology 1993;7:25–32. Sano T, Sasako M, Kinoshita T, Maruyama K. Recurrence of early gastric cancer: follow-up of 1475 patients and review of the Japanese literature.Cancer 1993;72:3174–8. Karpeh MS Jr, Brennan MF. Gastric carcinoma counterpoint. In: Johnson FE, Virgo KS, eds.Cancer Patient Follow-up. St. Louis: Mosby, 1997:100–3. Possik RA, Franco EL, Pires DR, Wohnrath DR, Ferreira EB. Sensitivity, specificity, and predictive value of laparoscopy for the staging of gastric cancer and for the detection of liver metastases.Cancer 1986;58:1–6. Kriplani AK, Kapur BM. Laparoscopy for pre-operative staging and assessment of operability in gastric carcinoma.Gastrointest Endosc 1991;37:441–3. O'Brien MG, Fitzgerald EF, Lee G, Crowley M, Shanahan F, O'Sullivan GS. A prospective comparison of laparoscopy and imaging in the staging of esophagogastric cancer before surgery.Am J Gastroenterol 1995;90:2191–4. Stell DA, Carter CR, Stewart I, Anderson JR. Prospective comparison of laparoscopy, ultrasonography and computed tomography in the staging of gastric cancer.Br J Surg 1996;83:1260–2. Bonavina L, Incarbone R, Lattuada E, Segalin A, Cesana B, Peracchia A. Preoperative laparoscopy in management of patients with carcinoma of the esophagus and of the esophagogastric junction.J Surg Oncol 1997;65:171–4.